Benign prostatic hyperplasia (BPH) can be considered a ‘normal’ part of the aging process in men, however your patients’ quality of life may be negatively affected. Symptoms related to BPH should not be accepted as part of the aging process and there are multiple technologies that address this condition. There are pharmaceutical medications available for BPH, but their effectiveness varies, and potential side effects can be present. 
View video

Technology animation video

Boston Scientific’s portfolio includes innovative therapies, from minimally invasive technologies to proven surgical solutions.

Dr. med. Claus Brunken, Department of Urology, Asklepios Westklinikum Hamburg, Germany, talks about photoselective vaporisation of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP), and their perioperative results. 

Dr. med. Claus Brunken Video
Stay up to date and subscribe to our newsletter :